208 Different prognostic impact of STK11 mutations in Non-Small-Cell Lung Cancer (NSCLC) illustrates the switch from a tumor suppressor to an oncogene. (September 2015) - Pecuchet, N.; Laurent-Puig, P.; Mansuet-Luppo, A.; Legras, A.; Alifano, M.; Pallier, K.; Didelot, A.; Gibault, L.; Danel, C.; Just, P.A.; Le Pimpec-Barthes, F.; Damotte, D.; et al.